GENMAB A/S (GMAB) Form 6-K — Jun 15, 2026
Genmab A/S announced that major shareholder Orbis Investment Management Limited reduced its stake in the company to 4.99% as of June 12, 2026. This reduction brought Orbis’s holding below the 5% threshold required for mandatory disclosure under the Danish Capital Markets Act. Orbis now controls voting rights for 3,112,476 shares, down from a previous reported position of 5.08%. The filing identifies the Allan & Gill Gray Foundation as the ultimate controlling entity behind the Orbis investment structure.
Key figures
- Shares Outstanding
- 62353067
- Threshold Crossed
- 5%
- Current Shares Owned
- 3112476
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.